CY2023 Q2
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| THE NEW YORK TIMES COMPANY | $96,787,000.00 | 2023-06-30 | View |
| BioLife Solutions, Inc. | $1,839,000.00 | 2023-06-30 | View |
| Cognex Corporation | $481,101,000.00 | 2023-07-02 | View |
| IONIS PHARMACEUTICALS, INC. | $466,979,000.00 | 2023-06-30 | View |
| NEUROCRINE BIOSCIENCES, INC. | $346,600,000.00 | 2023-06-30 | View |
| ELEVANCE HEALTH, INC. | $809,000,000.00 | 2023-06-30 | View |
| CARDIFF ONCOLOGY, INC. | $29,077,000.00 | 2023-06-30 | View |
| GLOBUS MEDICAL, INC. | $400,830,000.00 | 2023-06-30 | View |
| Alkermes plc. | $79,044,000.00 | 2023-06-30 | View |
| Techpoint, Inc. | $6,877,000.00 | 2023-06-30 | View |
| Acumen Pharmaceuticals, Inc. | $27,569,000.00 | 2023-06-30 | View |
| MARCUS & MILLICHAP, INC. | $74,758,000.00 | 2023-06-30 | View |
| SENTINELONE, INC | $400,846,000.00 | 2023-07-31 | View |
| AVITA MEDICAL, INC. | $2,759,000.00 | 2023-06-30 | View |
| ROOT, INC. | $165,900,000.00 | 2023-06-30 | View |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | $87,398,000.00 | 2023-06-30 | View |
| iTeos Therapeutics, Inc. | $78,886,000.00 | 2023-06-30 | View |
| HIPPO HOLDINGS INC. | $141,800,000.00 | 2023-06-30 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations